DNA ploidy and stroma predicted the risk of recurrence in low-risk stage III colorectal cancer.

MLA

Li, Yuan, et al. “DNA Ploidy and Stroma Predicted the Risk of Recurrence in Low-Risk Stage III Colorectal Cancer.” Clinical & Translational Oncology, vol. 25, no. 1, Jan. 2023, pp. 218–25. EBSCOhost, https://doi.org/10.1007/s12094-022-02930-8.

APA

Li, Y., Liao, L., Kong, L., Jiang, W., Tang, J., Han, K., Hou, Z., Zhang, C., Zhou, C., Zhang, L., Sui, Q., Xiao, B., Mei, W., Xu, Y., Yu, J., Hong, Z., Pan, Z., & Ding, P. (2023). DNA ploidy and stroma predicted the risk of recurrence in low-risk stage III colorectal cancer. Clinical & Translational Oncology, 25(1), 218–225. https://doi.org/10.1007/s12094-022-02930-8

Chicago

Li, Yuan, Leen Liao, Lingheng Kong, Wu Jiang, Jinghua Tang, Kai Han, Zhenlin Hou, et al. 2023. “DNA Ploidy and Stroma Predicted the Risk of Recurrence in Low-Risk Stage III Colorectal Cancer.” Clinical & Translational Oncology 25 (1): 218–25. doi:10.1007/s12094-022-02930-8.